Ranok Therapeutics Funding: $50M Raised, Series B (2021)
Ranok Therapeutics is based in Hangzhou, China. It has raised $50M in total funding. Latest round: Series B.
Ranok Therapeutics funding overview
Ranok Therapeutics is based in Hangzhou, China. Ranok Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for Ranok Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Lapam Capital, Shanghai Healthcare Capital, Wu Capital, Zhongguancun Kaiyuan Capital, Med-Find Capital, LC Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Ranok Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Ranok Therapeutics?
Lapam Capital, Shanghai Healthcare Capital, Wu Capital, Zhongguancun Kaiyuan Capital, Med-Find Capital, LC Ventures are named among the investors backing Ranok Therapeutics.
What was the latest Ranok Therapeutics funding round?
The most recent disclosed round is a Series B, announced in August 2021.
Where is Ranok Therapeutics based?
Ranok Therapeutics is based in Hangzhou, China.
When did Ranok Therapeutics last raise?
The last disclosed Ranok Therapeutics round closed in August 2021 at Series B.
We update the Ranok Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hangzhou and their backers are listed below.
